drugset / Trial / NCT00271336

Pentoxifylline in the Treatment of NEC in Premature Neonates

NCT00271336

Phase 2 Unknown 50 enrolled Shaare Zedek Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Pentoxifylline improves microcirculation and decreases TNF alpha levels associated with sepsis, rendering it of potential therapeutic value in necrotizing enterocolitis in premature neonates.

Timeline

Start
2005-01
Primary completion
2009-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentoxifylline Small molecule 5 mg/kg Intravenous